Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 5Phase 1 5Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 12Colonic Neoplasms 4Stomach Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Neuropathy, Painful 1Neuralgia 1Malignant Solid Tumour 1Liver Neoplasms 1Esophageal Neoplasms 1Cold Hypersensitivity 1Carcinoma, Hepatocellular 1CRC 1Advanced Colorectal Cancer 1

Interventions

pembrolizumab 43Nivolumab 24Gemcitabine 23Cyclophosphamide 21Paclitaxel 17Capecitabine 16fludarabine 14Ipilimumab 14aldesleukin 11Docetaxel 11130-nm albumin-bound paclitaxel 11Trastuzumab 10Cetuximab 10Bevacizumab 10Albumin-Bound Paclitaxel 9fludarabine phosphate 8Specimen Handling 8Interleukin-2 8Fluorouracil 8Cisplatin 8Biopsy 8Radiosurgery 7Oxaliplatin 7Irinotecan 7durvalumab 6avelumab 6Temozolomide 6Pemetrexed 6Leucovorin 6Carboplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasm Metastasis × Folfox protocol × Clear all
NCT01490996 2020-01-31

CUFOX

University of Leicester

Phase 1/2 Completed
41 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00494221 2014-03-27

A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

AstraZeneca

Phase 1/2 Completed
172 enrolled 12 charts
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡